Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ·Healthcare·Biotechnology
$14.75
+1.20%
Mkt Cap $6.38B
Analyst Ratings
Buy
8
Hold
2
Sell
0
Price Target (33 analysts)
$13.11
Range $5.00 – $20.00
Implied Upside
-11.1%
Consensus $13.11 vs current $14.75
NASDAQ·Healthcare·Biotechnology
$14.75
+1.20%
Mkt Cap $6.38B
Buy
8
Hold
2
Sell
0
Price Target (33 analysts)
$13.11
Range $5.00 – $20.00
-11.1%
Consensus $13.11 vs current $14.75